Clinical Trial Update: Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assesses conversion to sirolimus for recurrence of cytomegalovirus infection. The study is sponsored by Hospital do Rim e Hipert…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Hospital do Rim e Hipertensão | Conditions: Cytomegalovirus Infections | Phase 4 | Status: UNKNOWN